Skip to main content
Clinical Trials/ITMCTR2200006724
ITMCTR2200006724
Not yet recruiting
Phase 1

Transcutaneous electrical acupoint stimulation for patients Effect of transcutaneous electrical acupoint stimulation at Baihui (GV20) for patients with subjective cognitive decline: a clinical trialwith s

Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Subjective Cognitive Decline
Sponsor
Beijing University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Meeting the diagnostic criteria for SCD
  • 2\. Aged between 55 and 75 years
  • 3\. Chinese is the mother tongue, education level is more than 6 years, amd Mini\-mental State Examination (MMSE) score \>24
  • 4\. Can answer and complete the questionnaire smoothly

Exclusion Criteria

  • 1\. History of psychiatry (eg, bipolar, schizophrenia, anxiety, and depression)
  • 2\. History of drug abuse
  • 3\. History of a positive neurological diagnosis that could lead to cognitive decline (eg, VCIND, brain tumor, Parkinson's)
  • 4\. Presence of serious disease (eg, cancer, infection)
  • 5\. Received acupuncture or TEAS treatment in the past 1 month
  • 6\. With pacemaker
  • 7\. With scars or wounds on the skin of the acupoints
  • 8\. Enrolled in other trails in the past 1 month

Outcomes

Primary Outcomes

Not specified

Similar Trials